Aberrant methylation of the Ras-related Associated with Diabetes gene in human primary esophageal cancer

Anticancer Research

Volumn 33, Issue 11, 2013, Pages 5199-5204

  Jin, Zhe ^a,c   Feng, Xianling ^a   Jian, Qianhe ^a   Cheng, Yulan ^b   Gao, Yan ^d   Zhang, Xiaojing ^a   Wang, Liang ^a   Zhang, Yuan ^a   Huang, Weiling ^a   Fan, Xinmin ^a   Chen, Si ^a   Yu, Huimin ^a   Zhao, Zhenfu ^a   Dong, Ming ^a   Liu, Jie ^a   Mori, Yuriko ^b   Meltzer, Stephen J ^b  

^a Shenzhen University Health Science Center   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PEKING UNIVERSITY   (China)

^d Affiliated Shenzhen Sixth Hospital of Guangdong Medical University   (China)

Author keywords

EAC; ESCC; Hypermethylation; RRAD

Indexed keywords

GUANOSINE TRIPHOSPHATASE; RAS PROTEIN; RAS-RELATED ASSOCIATED WITH DIABETES; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA METHYLATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL;

EAC; ESCC; HYPERMETHYLATION; RRAD;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; RAS PROTEINS; ROC CURVE; SURVIVAL RATE;

EID: 84891362791     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Zhang XM and Guo MZ: The value of epigenetic markers in esophageal cancer. Front Med China 4: 378-384.
3. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, Cancer statastic 2012.
4. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA and Laird PW: Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61: 3410-3418, 2001.
5. Jin Z, Olaru A, Yang J, Sato F, Cheng Y, Kan T, Mori Y, Mantzur C, Paun B, Hamilton JP, Ito T, Wang S, David S, Agarwal R, Beer DG, Abraham JM and Meltzer SJ: Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer. Clin Cancer Res 13: 6293-6300, 2007.
6. Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, Agarwal R, David S, Abraham JM, Wolfsen HC, Wallace MB, Shaheen NJ, Washington K, Wang J, Canto MI, Bhattacharyya A, Nelson MA, Wagner PD, Romero Y, Wang KK, Feng Z, Sampliner RE and Meltzer SJ: A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res 69: 4112-4115, 2009.
7. Agarwal R, Jin Z, Yang J, Mori Y, Song JH, Kumar S, Sato M, Cheng Y, Olaru AV, Abraham JM, Verma A and Meltzer SJ: Epigenomic program of Barrett's-associated neoplastic progression reveals possible involvement of insulin signaling pathways. Endocr Relat Cancer 19: L5-9, 2012.
8. Jin Z, Mori Y, Yang J, Sato F, Ito T, Cheng Y, Paun B, Hamilton JP, Kan T, Olaru A, David S, Agarwal R, Abraham JM, Beer D, Montgomery E and Meltzer SJ: Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. Oncogene 26: 6332-6340, 2007.
9. Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054, 2003.
10. Reynet C and Kahn CR: Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science 262: 1441-1444, 1993.
11. Moyers JS, Bilan PJ, Reynet C and Kahn CR: Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells. J Biol Chem 271: 23111-23116, 1996.
12. Ridley AJ and Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399, 1992.
13. Ward Y, Yap SF, Ravichandran V, Matsumura F, Ito M, Spinelli B and Kelly K: The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway. J Cell Biol 157: 291-302, 2002.
14. Billiard J, Moran RA, Whitley MZ, Chatterjee-Kishore M, Gillis K, Brown EL, Komm BS and Bodine PV: Transcriptional profiling of human osteoblast differentiation. J Cell Biochem 89: 389-400, 2003.
15. Finlin BS, Crump SM, Satin J and Andres DA: Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases. Proc Natl Acad Sci USA 100: 14469-14474, 2003.
16. Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM, Syro LV, Kovacs K and Lloyd RV: Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 31: 2283-2290, 2011.
17. Wang JN, Shi N, Xie WB, Guo X and Chen SY: Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration. Arterioscler Thromb Vasc Biol 31: e19-26, 2011.
18. Fu M, Zhang J, Tseng YH, Cui T, Zhu X, Xiao Y, Mou Y, De Leon H, Chang MM, Hamamori Y, Kahn CR and Chen YE: Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration. Circulation 111: 1071-1077, 2005.
19. Sun Z, Zhang J, Chen C, Du Q, Chang L, Cao C, Zheng M, Garcia-Barrio MT, Chen YE, Xiao RP, Mao J and Zhu X: Rad GTPase induces cardiomyocyte apoptosis through the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 409: 52-57, 2011.
20. Suzuki M, Toyooka S, Shivapurkar N, Shigematsu H, Miyajima K, Takahashi T, Stastny V, Zern AL, Fujisawa T, Pass HI, Carbone M, and Gazdar AF: Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 24: 1302-1308, 2005.
21. Suzuki M, Shigematsu H, Shivapurkar N, Reddy J, Miyajima K, Takahashi T, Gazdar AF, and Frenkel EP: Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer. Cancer Lett 242: 222-230, 2006.
22. Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, Lieber A and Kiviat N: Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 15: 114-123, 2006.
23. Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Minna JD, Fujisawa T and Gazdar AF: Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers. Ann Surg Oncol 14: 1397-1404, 2007.
24. Mo Y, Midorikawa K, Zhang Z, Zhou X, Ma N, Huang G, Hiraku Y, Oikawa S and Murata M: Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinoma. Cancer Lett 2012.
25. Sato F, Jin Z, Schulmann K, Wang J, Greenwald BD, Ito T, Kan T, Hamilton JP, Yang J, Paun B, David S, Olaru A, Cheng Y, Mori Y, Abraham JM, Yfantis HG, Wu TT, Fredericksen MB, Wang KK, Canto M, Romero Y, Feng Z and Meltzer SJ: Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. PLoS One 3: e1890, 2008.
26. Hamilton JP, Sato F, Jin Z, Greenwald BD, Ito T, Mori Y, Paun BC, Kan T, Cheng Y, Wang S, Yang J, Abraham JM and Meltzer SJ: Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression. Clin Cancer Res 12: 6637-6642, 2006.
27. Tseng YH, Vicent D, Zhu J, Niu Y, Adeyinka A, Moyers JS, Watson PH and Kahn CR: Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. Cancer Res 61: 2071-2079, 2001.
28. Lee I, Yeom SY, Lee SJ, Kang WK and Park C: A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment. Cancer Res 70: 4357-4365, 2010.
29. Lin ZY and Chuang WL: Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells. Biomed Pharmacother 2012.
30. Hsiao BY, Chen CC, Hsieh PC, Chang TK, Yeh YC, Wu YC, Hsu HS, Wang FF and Chou TY: Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells. J Mol Med (Berl) 89: 481-492, 2011.
31. Luo Y, Zhang M, Zhang J, Chen C, Chen YE, Xiong JW and Zhu X: Platelet-derived growth factor induces Rad expression through Egr-1 in vascular smooth muscle cells. PLoS One 6: e19408, 2011.